adaptive immune system

(redirected from Acquired immune response)
Also found in: Medical.
Related to Acquired immune response: Adaptive immune system, antigen, humoral immune response, Innate immune response

adaptive immune system

n.
The component of the vertebrate immune system involving lymphocytes (B cells and T cells) containing a small number of proteins that combine to produce an enormous variety of distinct proteins capable of recognizing and deactivating specific antigens. It is one of two main components of the immune system, along with the innate immune system.
References in periodicals archive ?
Importantly, inhibition of MASP-2 does not appear to interfere with the antibody-dependent classical complement activation pathway, which is a critical component of the acquired immune response to infection, and its abnormal function is associated with a wide range of autoimmune disorders.
In contrast, some aspects of T and B cell responses, which form the acquired immune response, are usually overactive in these disorders.
The biochemical regulating cytokines, in the words of editors House (DynPort Vaccine Company, US) and Descotes (Poison Center and Pharmacovigilance Unit, Lyon Cedex, France), "facilitate the initial recognition of foreignness that launches innate host defenses, they form the bridge that allows a nonspecific response to mature into an antigen-specific acquired immune response, and they maintain this response for the life of the individual.
The FreshPack(R) microbial product line is focused in two new areas of crop benefits called growth promotion and acquired immune response.
Stull, Stull & Brody announced that it has filed a class action complaint on behalf of all persons who acquired Immune Response Corp.
OMS721 selectively inhibits MASP-2, blocking the lectin pathway of the complement system while leaving intact the classical pathway, or the acquired immune response to infection.
By selectively inhibiting MASP-2, OMS721 blocks the lectin pathway of the complement system while leaving intact the classical pathway, which represents the acquired immune response to infection.
OMS721 selectively inhibits MASP-2, blocking the lectin pathway of the complement system while leaving intact the classical pathway, which represents the acquired immune response to infection.
As we wrap up our CTA-enabling studies, OMS721 continues to impress with its potential competitive advantages, including subcutaneous administration, convenient dosing, and maintenance of the acquired immune response to infection," stated Gregory A.
As we continue to advance OMS721 through IND-enabling studies, we are pleased to see that our complement inhibitor is revealing its potential competitive advantages, including subcutaneous administration and maintenance of activity of the acquired immune response to infection," stated Gregory A.
These antibodies are expected to be delivered by a single subcutaneous or intramuscular injection and, equally important, to not interfere with the classical pathway - a critical component of the acquired immune response to infection.
Importantly, inhibition of MASP-2 does not appear to interfere with the antibody-dependent classical complement activation pathway, a central component of the acquired immune response to infection.

Full browser ?